Atrovent Hfa

Active Ingredient(s): Ipratropium Bromide
FDA Approved: * November 17, 2004
Pharm Company: * BOEHRINGER INGELHEIM
Category: Anticholinergic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Atrovent Hfa Overview

Ipratropium bromide, sold under the trade name Atrovent among others, is a medication which opens up the medium and large airways in the lungs.[1] It is used to treat the symptoms of chronic obstructive pulmonary disease and asthma.[1] It is used by inhaler or nebulizer.[1] Onset of action is typically within 15 to 30 minutes and lasts for three to five hours.[1] Common side effects include dry mouth, cough, and inflammation of t...

Read more Atrovent Hfa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ipratropium_bromide

Recent Atrovent Hfa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Atrovent Hfa: (2 results)

Sorted by National Drug Code

• 0597-0087 Atrovent 17 ug/1 Respiratory (Inhalation) Aerosol, Metered by Boehringer Ingelheim Pharmaceuticals Inc.
• 50090-0961 Atrovent 17 ug/1 Respiratory (Inhalation) Aerosol, Metered by A-s Medication Solutions

Other drugs which contain Ipratropium Bromide or a similar ingredient: (4 results)

• ATROVENT Ipratropium3 discussions
• IPRATROPIUM 3 discussions
• COMBIVENT RESPIMAT Ipratropium Bromide + Albuterol1 discussion
• IPRATROPIUM BROMIDE + ALBUTEROL

Related Atrovent Hfa Topics: